Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 873

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 873
---
 executive management purchased 35,000 shares of the Company’s common stock on the open market and one director of the Company purchased 5,000 shares of the Company’s common stock on the open market.

#### RSU Vesting
During the nine months ended September 30, 2023, the Company issued 100,000 shares of its common stock to members of the Company’s executive management and 10,000 shares to directors of the Company, upon vesting of restricted stock units.

#### Warrant Exercises
During the nine months ended September 30, 2023, the Company issued 3,000 shares of its common stock to members of the Company’s executive management and 60,000 shares to a director of the Company, upon exercise of outstanding warrants.

#### 14. Subsequent Events
The Company evaluated subsequent events through the date these consolidated financial statements were issued.

In October 2024, TuHURA exercised its right to extend the TuHURA Agreement and paid the Company $300,000 in Exclusivity Payments.

<div align='center'>F-141</div>

#### Annex A

### AGREEMENT AND PLAN OF MERGER
<div align='center'>among</div>

#### TUHURA BIOSCIENCES, INC.,

#### HURA MERGER SUB I, INC.

#### HURA MERGER SUB II, LLC

#### KINETA, INC.
<div align='center'>and</div>

#### CRAIG PHILIPS,
<div align='center'>**solely in his capacity as STOCKHOLDERS REPRESENTATIVE

Dated as of December 11, 2024**</div>

#### TABLE OF CONTENTSPageARTICLE ITHE MERGERSA-2Section 1.1The MergersA-2Section 1.2ClosingA-2Section 1.3Effective TimeA-2Section 1.4Effects of the MergersA-3Section 1.5Certificate of Incorporation; BylawsA-3Section 1.6Directors and Officers of the Surviving Entity and the Surviving CompanyA-3ARTICLE IIEFFECT ON THE CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS; EXCHANGE OF CERTIFICATESA-3Section 2.1Conversion of Capital StockA-3Section 2.2Agreements Relating to Company Stock Options and Company WarrantsA-4Section 2.3Disposed Asset Payment Right from Permitted Asset DispositionsA-5Section 2